• 1
    Banyai-Falger S, Maier U, Susani M, et al. High incidence of nephrogenic adenoma of the bladder after renal transplantation. Transplantation. 1998; 65: 511514.
  • 2
    Mostofi FK. Potentialities of bladder epithelium. J Urol. 1954; 71: 705714.
  • 3
    Peeker R, Aldenborg F, Fail M. Nephrogenic adenoma—a study with special reference to clinical presentation. Br J Urol. 1997; 80: 539542.
  • 4
    Corica FA, Husmann- DA, Churchill BM, et al. Intestinal metaplasia is not a strong risk factor for bladder cancer: study of 53 cases with long-term follow-up. Urology. 1997;50: 427431.
  • 5
    Oyama N, Tanase K, Akino H, Mori H, Kanamaru H, Okada K. Nephrogenic adenoma in a patient with transitional cell carcinoma of the bladder receiving intravesical bacillus Calmette-Guerin. Int J Urol. 1998; 5: 185187.
  • 6
    Schultz RE, Bloch MJ, Tomaszewski JE, Brooks JS, Hanno PM. Mesonephric adenocarcinoma of the bladder. J Urol. 1984; 132: 263265.
  • 7
    Pycha A, Mian C, Reiter WJ, et al. Nephrogenic adenoma in renal transplant recipients: a truly benign lesion? Urology. 1998; 52: 756761.
  • 8
    Koss LG, Wersto RP, Simmons DA, Deitch D, Herz F, Freed SZ. Predictive value of DNA measurements in bladder washings: comparison of flow cytometry, image cytophotometry, and cytology in patients with a past history of urothelial tumors. Cancer. 1989; 64: 916924.
  • 9
    Wiener HG, Remkes GW, Schatzl G, Susani M, Breitenecker G. Quick-staining urinary cytology and bladder wash image analysis with an integrated risk classification: a worthwhile improvement in the follow-up of bladder cancer? Cancer (Cytopathol). 1999; 87: 263269.
  • 10
    Fournier G, Menut P, Moal MC, Hardy E, Volant A, Mangin- P. Nephrogenic adenoma of the bladder in renal transplant recipients: a report of 9 cases with assessment of deoxyribonucleic acid ploidy and long-term follow up. J Urol. 1996;156: 4144.
  • 11
    UICC (Union Internationale Contre le Cancer). TMN classification of malignant tumors. 5th ed. Geneva: International Union Against Cancer. SobinLH, WittekindC, eds. New York: Wiley-Liss Inc.; 1997: 187190.
  • 12
    Epstein JI, Amin MB, Reuter VR, Mostofi FK, and the Bladder Consensus Conference Committee. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol. 1998;22: 14351448.
  • 13
    Wiener H, van't Hof-Grootenboer, Vooijs GP. Sum variance—a most valuable parameter in computer-assisted image analysis of voided urines. Cytopathology. 1996;7: 256261.
  • 14
    Böcking A, Adler CP, Common HD, Hilgarth M, Granyen B, Auffermann W. Algorithm for a DNA cytophotometric diagnosis and grading of malignancy. Anal Quant Cytol Histol. 1986; 6: 111.
  • 15
    Van der Poel HG, Witjes JA, van Stratum P, Boon ME, Debruyne FMJ, Schalken JA. Quanticyt: karyometric analysis of bladder washings for patients with superficial bladder cancer. Urology. 1996; 48: 357364.
  • 16
    Gonzalez JA, Watts JC, Alderson TP. Nephrogenic adenoma of the bladder: report of 10 cases. J Urol. 1988; 139: 4547.
  • 17
    Alsanjari N, Lynch MJ, Fisher C, Parkinson MC. Vesical clear cell carcinoma.V. Nephrogenic adenoma: a diagnostic problem. Histopathology. 1995; 27: 4349.
  • 18
    Gaylis FD, Keer HN, Bauer KD, Kozlowski JM, Grayhack JT. DNA profile of nephrogenic adenoma assessed by flow cytometry. Urology. 1993; 41: 160161.
  • 19
    Kontothanassis D, Christophis J, Tamvakis N, Becopoulos T. Bladder washing flow cytometry assessment of nephrogenic adenoma of the bladder. Int Urol Nephrol. 1996; 28: 495497.
  • 20
    Zeidan BS, Shabtao M, Waltzer WC, Miller F, Rapaport FT. Nephrogenic adenoma in renal transplant recipients. Transplant Proc. 1992; 24: 752754.
  • 21
    Mora LB, Nicosia SV, Pow Sang JM, et al. Ancillary techniques in the followup of transitional cell carcinoma: a comparison of cytology, histology and deoxyribonucleic acid image analysis cytometry in 91 patients. J Urol. 1996; 156: 4954.
  • 22
    Decker D, Stratmann H, Springer W, Schwering H, Varnai N, Bollmann R. Benign and malignant cells in effusions: diagnostic value of image DNA cytometry in comparison to cytological analysis. Pathol Res Pract. 1998; 194: 791795.
  • 23
    De la Roza, Hopkovitz A, Caraway NP, Kidd L, Dinney CP, Johnston D, Katz RL. DNA image analysis of urinary cytology: prediction of recurrent transitional cell carcinoma. Mod Pathol. 1996;9: 571578.
  • 24
    Rapi S, Caldini A, Fanelli A, et al. Flow cytometric measurement of DNA content in human solid tumors: a comparison with cytogenetics. Cytometry. 1996; 26: 192197.
  • 25
    Pantazopoulos D, Ioakim Liossi A, Karakitsos P, et al. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder. Anticancer Res. 1997; 17: 781786.
  • 26
    Shankey TV, Rabinovitch PS, Bagwell B, et al. Guidelines for implementation of clinical DNA cytometry. Cytometry. 1993; 14: 472477.
  • 27
    Wheeless LL, Badalament RA, DeVere White RW, Fradet Y, Tribukait B. Consensus review of the clinical utility of DNA cytometry in bladder cancer. Cytometry. 1993; 14: 478481.
  • 28
    Haroske G, Giroud F, Reith A, Bocking A. 1997 ESACP consensus report on diagnostic DNA image cytometry. Part I: basic considerations and recommendations for preparation, measurement and interpretation. European Society for Analytical Cellular Pathology. Anal Cell Pathol. 1998; 17: 189200.
  • 29
    Kurth KH, Denis L, Bouffioux Ch, et al. Factors affecting recurrence and progression in superficial bladder tumours. Eur J Cancer. 1995;31A: 18401846.